Cancer feature: cnaSKCM4

ACER2 ADAMTSL1 AK3 BNC2 C9orf53 C9orf72 C9orf92 CAAP1 CCDC171 CD274 CDC37L1 CDKN2A CDKN2B CER1 CNTLN DENND4C DMRT1 DMRT2 DMRT3 DMRTA1 ELAVL2 EQTN ERMP1 FAM154A FOCAD FREM1 GLDC GLIS3 HAUS6 IFNA1 IFNA10 IFNA13 IFNA14 IFNA16 IFNA17 IFNA2 IFNA21 IFNA4 IFNA5 IFNA6 IFNA7 IFNA8 IFNB1 IFNE IFNK IFNW1 IFT74 IL33 INSL4 INSL6 IZUMO3 JAK2 KCNV2 KDM4C KIAA0020 KIAA1432 KIAA2026 KLHL9 LINGO2 LRRC19 LURAP1L MLANA MLLT3 MOB3B MPDZ MTAP NFIB PDCD1LG2 PLAA PLGRKT PLIN2 PPAPDC2 PSIP1 PTPLAD2 PTPRD RANBP6 RCL1 RFX3 RLN1 RLN2 RP11-145E5.5 RPS6 RRAGA SH3GL2 SLC1A1 SLC24A2 SMARCA2 SNAPC3 SPATA6L TEK TMEM261 TPD52L3 TTC39B TUSC1 TYRP1 UHRF2 VLDLR ZDHHC21

Known Driver Genes: CDKN2A,JAK2

Copy number alternation: loss

SGC-CBP30

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).

Genomics of Drug Sensitivity in Cancer